declin
protect
immun
respons
follow
vaccin
one
main
featur
immunosenesc
improv
vaccin
candid
elderli
adult
thu
urgent
need
scientif
regulatori
requir
new
vaccin
must
first
evalu
preclin
level
continu
quest
ideal
anim
model
perform
studi
main
advantag
limit
murin
model
commonli
use
human
vaccin
research
larg
anim
model
review
discuss
age
associ
profound
alter
immun
system
collect
term
immunosenesc
chang
contribut
increas
suscept
infecti
diseas
reactiv
latent
infect
declin
protect
immun
respons
vaccin
observ
mani
adult
year
age
jefferson
et
al
goodwin
et
al
kovaiou
et
al
kumar
burn
although
exist
vaccin
significantli
reduc
risk
complic
death
infect
elderli
compar
younger
individu
mcelhaney
vilacorcol
develop
new
vaccin
capabl
overcom
defect
age
still
urgent
need
scientif
regulatori
requir
includ
safeti
concern
improv
vaccin
candid
older
adult
first
evalu
appropri
anim
model
relev
result
obtain
model
influenc
select
anim
speci
often
mice
speci
choic
develop
human
vaccin
includ
target
elderli
gerdt
et
al
among
major
advantag
age
murin
model
commerci
avail
age
mice
possibl
rais
rel
easili
anim
facil
welldefin
genet
background
health
statu
eas
handl
rel
costeffect
possibl
genet
manipul
avail
wide
rang
specif
immunolog
tool
importantli
senesc
mice
shown
display
alter
immun
respons
vaccin
eg
influenza
mbawuik
et
al
asanuma
et
al
reproduc
featur
immun
defect
elderli
deng
et
al
goodwin
et
al
util
age
mous
model
evalu
immunogen
efficaci
novel
vaccin
older
individu
report
sever
infecti
diseas
patholog
influenza
respiratori
syncyti
viru
sever
acut
respiratori
syndrom
coronaviru
sarscov
cancer
mbawuik
et
al
sambhara
et
al
zhang
et
al
vogel
et
al
posnett
et
al
furthermor
capac
vaccin
candid
effici
restor
defici
immun
senesc
mice
subsequ
confirm
age
human
higgin
et
al
de
donato
et
al
podda
holland
et
al
despit
multipl
advantag
rodent
model
associ
number
limit
regard
vaccin
practic
inject
vaccin
volum
mous
gener
proport
man
eg
intramuscular
rout
volum
ml
inject
mous
quadricep
muscl
versu
ml
human
deltoid
muscl
furthermor
inject
site
therefor
lymph
node
target
immun
often
differ
mice
man
may
lead
possibl
differ
immun
respons
strict
intranas
immun
difficult
carri
mice
potenti
risk
inhal
intrapulmonari
rout
ingest
oral
rout
vaccin
antigen
intraderm
rout
skin
structur
composit
differ
greatli
mice
man
respect
vaccin
efficaci
studi
mani
mous
model
extens
use
inbr
popul
requir
artifici
challeng
rout
excess
infect
dose
due
hostspecif
pathogen
marco
et
al
barbour
et
al
impact
relev
diseas
pathogenesi
immun
correl
protect
observ
model
compar
man
subbarao
robert
gerdt
et
al
regard
safeti
concern
murin
model
may
also
unabl
predict
certain
sideeffect
potenti
occur
vaccin
peopl
instanc
transgen
mice
creat
model
alzheim
diseas
ad
immun
fibrillar
bamyloid
peptid
ab
show
signific
reduct
cerebr
ab
deposit
improv
behaviour
deficit
schenk
et
al
morgan
et
al
develop
haemorrhag
encephalit
complic
clinic
observ
among
vaccin
ad
patient
phase
ii
clinic
trial
orgogozo
et
al
investig
vaccin
respons
geriatr
anim
mice
limit
use
larg
age
anim
model
might
great
interest
hein
griebel
gerdt
et
al
particular
larg
outbr
anim
often
permit
use
compar
rout
volum
vaccin
similar
rout
dose
challeng
use
man
therebi
allow
collect
relev
correl
immunemedi
protect
peopl
larger
speci
pig
also
consid
appropri
model
either
mucos
cutan
immun
recent
effect
interleukin
il
treatment
improv
immun
influenza
vaccin
report
age
rhesu
macaqu
aspinal
et
al
likewis
field
therapeut
vaccin
ad
studi
initi
limit
number
old
rhesu
monkey
assess
efficaci
safeti
ab
immun
consid
nonhuman
primat
humanlik
immun
system
rodent
natur
develop
ab
patholog
age
gandi
howev
studi
involv
larger
number
macaqu
requir
see
whether
signific
proport
develop
allerg
enceph
observ
abvaccin
peopl
geriatr
hors
might
also
promis
model
test
new
vaccin
age
peopl
arora
et
al
muirhead
et
al
investig
need
main
disadvantag
associ
larg
anim
model
resid
high
cost
need
specif
handl
skill
dedic
hous
facil
avail
rel
low
number
may
impact
statist
relev
studi
conduct
speci
moreov
limit
knowledg
immun
system
model
particular
geriatr
larg
anim
specif
immunolog
tool
avail
data
shown
immun
system
rumin
especi
sheep
cattl
well
pig
contain
mani
cell
express
gd
tcell
receptor
tcr
man
hein
mackay
takamatsu
et
al
furthermor
substanti
proport
extrathym
doubl
posit
cell
describ
pig
et
al
cell
rare
present
human
peripher
blood
particular
like
gener
differ
immun
respons
vaccin
larg
anim
peopl
use
relev
anim
model
develop
test
novel
vaccin
elderli
crucial
human
vaccin
research
gener
select
appropri
model
prerequisit
transfer
success
result
preclin
research
clinic
applic
avail
anim
model
perfect
fulli
replic
complex
age
human
situat
preimmun
statu
human
due
multipl
previou
infecti
episod
andor
vaccin
may
differ
anim
confound
factor
eg
health
statu
use
medic
person
habit
difficult
reproduc
preclin
level
howev
use
anim
lack
complex
may
allow
better
demonstr
improv
immunogen
candid
vaccin
relev
anim
model
necessarili
least
expens
conveni
one
need
acquir
data
immun
system
larg
anim
speci
particular
age
author
invit
speaker
merial
european
compar
vaccinolog
symposium
receiv
travel
expens
present
